Alzheimer's disease & dementia

Researchers find new target for Alzheimer's drug development

Researchers at the University of Minnesota's Center for Drug Design have developed a synthetic compound that, in a mouse model, successfully prevents the neurodegeneration associated with Alzheimer's disease.

Psychology & Psychiatry

Protecting your brain: 'Use it or lose it'

The findings of a new study suggest that the protective effects of an active cognitive lifestyle arise through multiple biological pathways.

Alzheimer's disease & dementia

Cancer drug improves memory in mouse model of Alzheimer's disease

A compound that previously progressed to Phase II clinical trials for cancer treatment slows neurological damage and improves brain function in an animal model of Alzheimer's disease, according to a study in the March 14 ...

Neuroscience

Alzheimer's: French scientists focus on key target

French scientists said on Tuesday that lack of a key brain protein was linked to Alzheimer's, a finding that threw up a tempting target for drugs to fight the disease.

Neuroscience

Characterizing a toxic offender

The brains of individuals with Alzheimer's disease contain protein aggregates called plaques and tangles, which interfere with normal communication between nerve cells and cause progressive learning and memory deficits. Now, ...

page 12 from 14